Comments on: Vaccine Impresario, Todd Patrick, At it Again With Immunization Against Strep Throat http://www.xconomy.com/seattle/2008/11/18/vaccine-impresario-todd-patrick-at-it-again-with-immunization-against-strep-throat/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 03:54:18 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: David Miller http://www.xconomy.com/seattle/2008/11/18/vaccine-impresario-todd-patrick-at-it-again-with-immunization-against-strep-throat/comment-page-1/#comment-40448 David Miller Tue, 18 Nov 2008 17:30:52 +0000 http://www.xconomy.com/?p=6299#comment-40448 Our firm covered Todd and Tony's ID Biomedical from way back. I got to know them pretty well, especially Todd. I joke with Todd all the time that he left money on the table getting "only" $1.5B for ID, but there is no getting around the fact he did really well for shareholders. We see a lot of schlock out there among biotech companies on the public exchanges. Between pharma cherry picking private companies and no IPO flow, the pickings are pretty slim. We'd be really happy if Todd decided to take this venture public, and I expect we wouldn't be the only ones -- even in this market. Our firm covered Todd and Tony’s ID Biomedical from way back. I got to know them pretty well, especially Todd. I joke with Todd all the time that he left money on the table getting “only” $1.5B for ID, but there is no getting around the fact he did really well for shareholders.

We see a lot of schlock out there among biotech companies on the public exchanges. Between pharma cherry picking private companies and no IPO flow, the pickings are pretty slim. We’d be really happy if Todd decided to take this venture public, and I expect we wouldn’t be the only ones — even in this market.

]]>